Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00575445 · ClinicalTrials.gov registry record
The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients
A clinical trial, sponsored by Akron Children's Hospital.
- Terminated
- Registry status
- 100
- Enrollment target
NCT00575445 is a clinical trial that was terminated before completion, run by Akron Children's Hospital. The registered enrollment target is 100 participants.
The verdict
NCT00575445 was terminated before completion, sponsored by Akron Children's Hospital.
- TERMINATED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if exhaled nitric oxide (eNO) levels will be increased in pediatric patients with uncontrolled asthma as determined by the Asthma Control Test (ACT). During the study the investigators will also examine if the combination of eNO and ACT will better predict asthma control that either tool alone when compared to a medical provider's assessment of the patient's asthma control.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2007-11 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00575445
The ClinicalTrials.gov registry entry for NCT00575445 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akron Children's Hospital, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00575445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00575445 about?
NCT00575445 is a clinical study titled "The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients". The purpose of this study is to determine if exhaled nitric oxide (eNO) levels will be increased in pediatric patients with uncontrolled asthma as determined by the Asthma Control Test (ACT). During the study the investigators will also examine if the combination of eNO and ACT will better predict a...
What is the current status of trial NCT00575445?
This trial is currently terminated. The enrollment target is 100 participants. The study started on 2007-11. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT00575445?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.